Related Experiment Video
Updated: Feb 26, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Venom-derived peptides inhibiting Kir channels: Past, present, and future
1Department of Molecular Pharmacology & Physiology, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612, United States.
Few venom toxins target inwardly rectifying potassium (Kir) channels. Discovering new Kir channel blockers, like tertiapin from bee venom, is crucial for research and therapeutics.
Area of Science:
- Ion channel research
- Venom-derived peptides
- Pharmacology
Background:
- Inwardly rectifying K+ (Kir) channels are vital for membrane transport and excitability in vertebrates and invertebrates.
- Few potent and selective venom toxins targeting Kir channels have been identified compared to other K+ channel families.
Observation:
- The limited discovery of Kir channel toxins may stem from evolutionary pressures or a lack of focused screening.
- Screening efforts have identified three venom peptides with inhibitory activity against mammalian Kir channels.
- Tertiapin, a potent pore blocker from European honey bee venom (Apis mellifera), is a key example.
Findings:
- Venomics and computational approaches offer new avenues for venom peptide discovery.
- Re-engineering existing peptide scaffolds, such as tertiapin, can expand the range of Kir channel blockers.
Implications:
- Expanding the toolkit of selective Kir channel blockers is essential for future research.
- These blockers hold potential for developing novel therapeutics.
- This work contributes to understanding venom evolution and peptide-based drug development.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

